Publications by authors named "Patrick Connor Johnson"

Claim this Profile
P
Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US.
Erin Mulvey, Jason Shafrin, Kyi-Sin Than, Sanjana Muthukrishnan, Alex Mutebi, Patrick Connor Johnson

Future Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central nervous system involvement in chronic lymphocytic leukemia: a real-world analysis.
Catherine Cho, Robert Redd, Julie Erika Haydu, Patrick Connor Johnson, Jeffrey A Barnes

Leuk Lymphoma· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients' and caregivers' perspectives on preparedness for and experience with chimeric antigen receptor T-cell therapy.
Anna Barata, Bridget Coffey, Hermioni L Amonoo, Lara Traeger, Ashley M Nelson, Patrick Connor Johnson

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5-5-5 ABRT (Dose of 5 Gy per Fraction for up to 5 Fractions Over 5 Weeks Adaptive Bridging Radiation Therapy)-Artificial Intelligence Enters the CAR (-T) (Chimeric Antigen Receptor-T) in Relapsed/Refractory Large B Cell Lymphoma.
Hazim S Ababneh, Andrea K Ng, Joshua Wan, Tyler Walburn, Lin Zhu, Patrick Connor Johnson

Int J Radiat Oncol Biol Phys· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet needs and lived experience of patients receiving CAR T-cell therapy.
Patrick J O'Shea, Patrick Connor Johnson, Areej El-Jawahri, Thomas W Leblanc

Leuk Lymphoma· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a realworld analysis from 21 US centers.
Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Patrick Connor Johnson

Haematologica· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation.
Anita Kumar, Jacob Soumerai, Jeremy S Abramson, Jeffrey A Barnes, Philip Caron, Patrick Connor Johnson

Blood· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life Evaluation in Patients with Follicular Cell Lymphoma: A Real-World Study in Europe and the United States.
Patrick Connor Johnson, Abigail Bailey, Qiufei Ma, Neil Milloy, Emilia Biondi

Adv Ther· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salvage radiotherapy in relapsed/refractory large B-cell lymphoma after failure of CAR T-cell therapy.
Hazim S Ababneh, Andrea K Ng, Matthew J Frigault, Jeremy S Abramson, Patrick Connor Johnson

Haematologica· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myeloma.
Kevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, Jacob D Soumerai, Andrew J Yee

Blood Cancer J· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coping strategies in patients with acute myeloid leukemia.
Hermioni L Amonoo, Monica H Bodd, Matthew J Reynolds, Ashley M Nelson, Richard Newcomb, Patrick Connor Johnson

Blood Adv· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasmacytoma presenting as jugular foramen tumor in a young woman with multiple myeloma.
Joan How, Patrick Connor Johnson, Carleton Eduardo Corrales, Kyle Wright, Natalie Justicz

Am J Hematol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis